ReviewArchives of microbiology2026
Unveiling the diversity, bioactive metabolites and therapeutic potential of endophytic fungi of the Apocynaceae family: a comprehensive review.
Review in Archives of microbiology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The Apocynaceae family, commonly known as the dogbane family, is widely distributed in tropical and subtropical regions and is renowned for its rich reservoir of bioactive phytochemicals. Although its plants have been extensively investigated, the fungal endophytes associated with this family remain comparatively less explored. This review provides a comprehensive synthesis of the diversity, bioactive metabolites, therapeutic potential, plant growth-promoting attributes, and nanoparticle synthesis associated with endophytic fungi of plants of Apocynaceae family. The review summarizes endophytic fungi reported from major medicinal hosts, including Catharanthus roseus, Calotropis procera, Nerium oleander, and Rauvolfia serpentina. Species belonging to the genera Alternaria, Aspergillus, Penicillium, Fusarium, Curvularia, and Cladosporium were the most frequently reported fungal endophytes. These fungi produce a wide range of secondary metabolites, including vinblastine, vincristine, taxol, oosporein, polyketides, coumarins, terpenoids, alkaloids, phenolics, and steroids, exhibiting diverse biological activities such as cytotoxic, antimicrobial, antioxidant, antidiabetic, anti-inflammatory, and insecticidal. The review further discusses emerging advances in omics-based approaches, biosynthetic gene clusters, plant growth-promoting attributes, and nanoparticle synthesis using fungal extracts, while highlighting current challenges in validating host-associated metabolites and identifying future research priorities for the sustainable exploitation of plants of Apocynaceae-associated fungal endophytes.
Indexed as
Identifiers
42565870What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.